Last reviewed · How we verify

RS-C1001

Peking University First Hospital · Phase 1 active Small molecule Quality 0/100

At a glance

Generic nameRS-C1001
SponsorPeking University First Hospital
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results